HealthLeaders Media June 23, 2021
Jack O'Brien

PwC attributed the increase in deal activity to several factors, including “capital availability, regulatory shifts, evolving competitive dynamics, promising technologies and commitments to patient-centricity.”

Deal volumes in the health services sector this year are “unprecedented,” according to a PricewaterhouseCoopers (PwC) report released Tuesday afternoon.

Following a slump in early 2020, coinciding with the start of the domestic spread of COVID-19, health services deals rebounded with 352 transactions in Q4 2020, a record for one quarter, only to be topped by 426 deals in Q1 2021. Additionally, the sector has seen six ‘megadeals’ valued at more than $5 billion. 

PwC attributed the increase in deal activity to several factors, including “capital availability, regulatory shifts, evolving competitive dynamics, promising technologies and commitments to...

Today's Sponsors

ZeOmega
Holon
Transcarent

Today's Sponsors

Crossover Health
Qure4u

Today's Sponsor

Institute for Healthcare Improvement

 
Topics: Mergers & Acquisitions / JV, Pharma / Biotech, Provider, Survey / Study, Trends
Datavant, Ciox Health close $7B merger: 4 details
With Amwell’s deal, the acquisition race heats up in telehealth
Komodo Health's Breakaway Partners acquisition expands startup's footprint in life sciences enterprise market
Amwell scoops up two digital health companies for $320M as tech M&A heats up
Kindred at Home Deal to Bolster Humana’s Performance Via Value-Based Arrangements